NCT00897312: Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease |
|
|
| Terminated | N/A | 7 | US | infliximab, Remicade, pegylated interferon alfa, pegylated interferon-a, ticilimumab, CP-675206, ribavirin, Copegus, Rebetol, Ribasphere, high performance liquid chromatography, not noted, laboratory biomarker analysis | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Melanoma | 08/08 | 08/08 | | |
